Clario, a prominent healthcare research and technology company specializing in clinical trial solutions, has announced its acquisition of ArtiQ, a technology firm known for its expertise in artificial intelligence (AI). This strategic move bolsters Clario’s Respiratory Solutions portfolio, empowering the company to further harness AI’s potential across its service lines. With a focus on improving the quality and efficiency of clinical trial execution, Clario aims to leverage ArtiQ’s technology to scale AI for overreading, ensuring data quality and streamlining processes for patients globally.
Become a Subscriber
Please purchase a subscription to continue reading this article.
Subscribe Now
Marko Topalovic, the …
Read more…….
